{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T19:13:19Z","timestamp":1785870799738,"version":"3.56.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82000740"],"award-info":[{"award-number":["82000740"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82170845"],"award-info":[{"award-number":["82170845"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008081","name":"Southeast University","doi-asserted-by":"publisher","award":["2022ZDSYLL318-P01"],"award-info":[{"award-number":["2022ZDSYLL318-P01"]}],"id":[{"id":"10.13039\/501100008081","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002949","name":"Government of Jiangsu Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002949","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002338","name":"Ministry of Education of the People's Republic of China","doi-asserted-by":"publisher","award":["2024EME001"],"award-info":[{"award-number":["2024EME001"]}],"id":[{"id":"10.13039\/501100002338","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002338","name":"Ministry of Education of the People's Republic of China","doi-asserted-by":"publisher","award":["NCT05597709"],"award-info":[{"award-number":["NCT05597709"]}],"id":[{"id":"10.13039\/501100002338","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.eprac.2024.09.012","type":"journal-article","created":{"date-parts":[[2024,9,25]],"date-time":"2024-09-25T16:37:42Z","timestamp":1727282262000},"page":"1171-1179","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Comparison of Risk Factors Between Lean and Nonlean Metabolic Dysfunction-Associated Steatotic Liver Disease in Individuals With Type 2 Diabetes: A Multicenter Study"],"prefix":"10.1016","volume":"30","author":[{"given":"Weixia","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingqi","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hekai","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"He","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingzhao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Congqing","family":"Miao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen J.","family":"Pandol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.eprac.2024.09.012_bib1","article-title":"The coexistence of nonalcoholic fatty liver disease and type 2 diabetes mellitus","volume":"11","author":"Kosmalski","year":"2022","journal-title":"J\u00a0Clin Med"},{"key":"10.1016\/j.eprac.2024.09.012_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2023.108372","article-title":"Endotheliopathy in the metabolic syndrome: mechanisms and clinical implications","volume":"244","author":"Furuta","year":"2023","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.eprac.2024.09.012_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.plipres.2023.101250","article-title":"Triacylglycerol uptake and handling by macrophages: from fatty acids to lipoproteins","volume":"92","author":"Deng","year":"2023","journal-title":"Prog Lipid Res"},{"issue":"3","key":"10.1016\/j.eprac.2024.09.012_bib4","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1002\/hep.32581","article-title":"Myeloid p38 activation maintains macrophage-liver crosstalk and BAT thermogenesis through IL-12-FGF21 axis","volume":"77","author":"Crespo","year":"2023","journal-title":"Hepatology"},{"issue":"7","key":"10.1016\/j.eprac.2024.09.012_bib5","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.2337\/dc20-3175","article-title":"The relationship between body fat distribution and nonalcoholic fatty liver in adults with type 1 diabetes","volume":"44","author":"Parente","year":"2021","journal-title":"Diabetes Care"},{"issue":"2","key":"10.1016\/j.eprac.2024.09.012_bib6","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s00018-022-04629-z","article-title":"Hepatocyte PPAR\u03b3 contributes to the progression of non-alcoholic steatohepatitis in male and female obese mice","volume":"80","author":"Lee","year":"2023","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.eprac.2024.09.012_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.jlr.2021.100104","article-title":"Nonalcoholic fatty liver disease stratification by liver lipidomics","volume":"62","author":"Vvedenskaya","year":"2021","journal-title":"J\u00a0Lipid Res"},{"issue":"10","key":"10.1016\/j.eprac.2024.09.012_bib8","doi-asserted-by":"crossref","first-page":"2597","DOI":"10.1016\/j.cgh.2023.01.018","article-title":"Saroglitazar, a dual PPAR \u03b1\/\u03b3 agonist, improves atherogenic dyslipidemia in patients with non-cirrhotic nonalcoholic fatty liver disease: a pooled analysis","volume":"21","author":"Siddiqui","year":"2023","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.eprac.2024.09.012_bib9","doi-asserted-by":"crossref","first-page":"e573","DOI":"10.1016\/j.cgh.2021.02.030","article-title":"Estimating global prevalence of metabolic dysfunction-associated fatty liver disease in overweight or obese adults","volume":"20","author":"Liu","year":"2022","journal-title":"Clin Gasteroenterol Hepatol"},{"issue":"9","key":"10.1016\/j.eprac.2024.09.012_bib10","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1093\/cvr\/cvad095","article-title":"Non-alcoholic fatty liver disease: pathophysiological concepts and treatment options","volume":"119","author":"Grander","year":"2023","journal-title":"Cardiovasc Res"},{"issue":"3","key":"10.1016\/j.eprac.2024.09.012_bib11","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1053\/j.gastro.2022.06.023","article-title":"AGA Clinical practice update: diagnosis and management of nonalcoholic fatty liver disease in lean individuals: expert review","volume":"163","author":"Long","year":"2022","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.eprac.2024.09.012_bib12","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.1186\/s12889-022-14362-8","article-title":"Prevalence of prediabetes and diabetes vary by ethnicity among U.S. Asian adults at healthy weight, overweight, and obesity ranges: an electronic health record study","volume":"22","author":"Vicks","year":"2022","journal-title":"BMC Public Health"},{"key":"10.1016\/j.eprac.2024.09.012_bib13","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.diabres.2018.09.011","article-title":"Ethnic differences in the prevalence of diabetes in underweight and normal weight individuals: the CARRS and NHANES studies","volume":"146","author":"Gujral","year":"2018","journal-title":"Diabetes Res Clin Pract"},{"issue":"9403","key":"10.1016\/j.eprac.2024.09.012_bib14","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0140-6736(03)15268-3","article-title":"Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies","volume":"363","year":"2004","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.eprac.2024.09.012_bib15","first-page":"691","article-title":"Diagnostic value of FibroTouch in identifying hepatic steatosis in NAFLD with MRI-PDFF as the reference standard","volume":"24","author":"Mu","year":"2023","journal-title":"J\u00a0Dig Dis"},{"issue":"4","key":"10.1016\/j.eprac.2024.09.012_bib16","doi-asserted-by":"crossref","DOI":"10.14309\/ctg.0000000000000323","article-title":"Diagnostic performance of FibroTouch ultrasound attenuation parameter and liver stiffness measurement in assessing hepatic steatosis and fibrosis in patients with nonalcoholic fatty liver disease","volume":"12","author":"Qu","year":"2021","journal-title":"Clin Transl Gastroenterol"},{"issue":"4","key":"10.1016\/j.eprac.2024.09.012_bib17","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1053\/j.gastro.2023.05.053","article-title":"Prevalence of liver steatosis and fibrosis in the general population and various high-risk populations: a nationwide study with 5.7 million adults in China","volume":"165","author":"Man","year":"2023","journal-title":"Gastroenterology"},{"issue":"10","key":"10.1016\/j.eprac.2024.09.012_bib18","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000024940","article-title":"Prevalence and risk factor analysis for\u00a0the\u00a0nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus","volume":"100","author":"Zhou","year":"2021","journal-title":"Medicine"},{"issue":"4","key":"10.1016\/j.eprac.2024.09.012_bib19","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0266069","article-title":"Liver stiffness as surrogate parameter in emergency assessment for inpatient health care utilization","volume":"17","author":"Kaddu-Mulindwa","year":"2022","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.eprac.2024.09.012_bib20","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S2468-1253(20)30077-7","article-title":"Global prevalence, incidence, and outcomes of non-obese or lean non-alcoholic fatty liver disease: a systematic review and meta-analysis","volume":"5","author":"Ye","year":"2020","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"10","key":"10.1016\/j.eprac.2024.09.012_bib21","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1016\/j.cgh.2021.11.004","article-title":"Clinical and patient-reported outcomes from patients with nonalcoholic fatty liver disease across the world: data from the global non-alcoholic steatohepatitis (NASH)\/ non-alcoholic fatty liver disease (NAFLD) registry","volume":"20","author":"Younossi","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"4","key":"10.1016\/j.eprac.2024.09.012_bib22","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1097\/MCG.0000000000001270","article-title":"The prevalence of lean\/nonobese nonalcoholic fatty liver disease: a systematic review and meta-analysis","volume":"54","author":"Shi","year":"2020","journal-title":"J\u00a0Clin Gastroenterol"},{"issue":"1","key":"10.1016\/j.eprac.2024.09.012_bib23","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/hep.28431","article-title":"Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"issue":"8","key":"10.1016\/j.eprac.2024.09.012_bib24","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2019-036663","article-title":"Prevalence trends in non-alcoholic fatty liver disease at the global, regional and national levels, 1990-2017: a population-based observational study","volume":"10","author":"Ge","year":"2020","journal-title":"BMJ Open"},{"issue":"9","key":"10.1016\/j.eprac.2024.09.012_bib25","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1038\/ajg.2015.235","article-title":"Prevalence and severity of nonalcoholic fatty liver disease in non-obese patients: a population study using proton-magnetic resonance spectroscopy","volume":"110","author":"Wei","year":"2015","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"10.1016\/j.eprac.2024.09.012_bib26","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s00535-014-0948-9","article-title":"Prevalence of and risk factors for non-alcoholic fatty liver disease in a non-obese Japanese population, 2011-2012","volume":"50","author":"Nishioji","year":"2015","journal-title":"J\u00a0Gastroenterol"},{"key":"10.1016\/j.eprac.2024.09.012_bib27","article-title":"Metabolic (dysfunction)-associated fatty liver disease in Chinese patients with type 2 diabetes from a subcenter of the national metabolic management center","volume":"2022","author":"Guan","year":"2022","journal-title":"J\u00a0Diabetes Res"},{"issue":"10","key":"10.1016\/j.eprac.2024.09.012_bib28","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1038\/s41575-022-00635-5","article-title":"Metabolic (dysfunction)-associated fatty liver disease in individuals of normal weight","volume":"19","author":"Eslam","year":"2022","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"13","key":"10.1016\/j.eprac.2024.09.012_bib29","doi-asserted-by":"crossref","DOI":"10.3390\/nu15132856","article-title":"Metabolic and risk profiles of lean and non-lean hepatic steatosis among US adults","volume":"15","author":"Li","year":"2023","journal-title":"Nutrients"},{"issue":"2","key":"10.1016\/j.eprac.2024.09.012_bib30","doi-asserted-by":"crossref","first-page":"290","DOI":"10.5009\/gnl210084","article-title":"Cardiovascular risk is elevated in lean subjects with nonalcoholic fatty liver disease","volume":"16","author":"Kim","year":"2022","journal-title":"Gut Liver"},{"issue":"4","key":"10.1016\/j.eprac.2024.09.012_bib31","first-page":"362","article-title":"Pathogenesis of insulin resistance and atherogenic dyslipidemia in nonalcoholic fatty liver disease","volume":"7","author":"Akhtar","year":"2019","journal-title":"J\u00a0Clin Transl Hepatol"},{"issue":"3","key":"10.1016\/j.eprac.2024.09.012_bib32","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1194\/jlr.M081836","article-title":"Interplay between ChREBP and SREBP-1c coordinates postprandial glycolysis and lipogenesis in livers of mice","volume":"59","author":"Linden","year":"2018","journal-title":"J\u00a0Lipid Res"},{"issue":"1","key":"10.1016\/j.eprac.2024.09.012_bib33","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1007\/s00125-022-05803-5","article-title":"Liver, visceral and subcutaneous fat in men and women of South Asian and white European descent: a systematic review and meta-analysis of new and published data","volume":"66","author":"Iliodromiti","year":"2023","journal-title":"Diabetologia"},{"key":"10.1016\/j.eprac.2024.09.012_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2021.101238","article-title":"Metabolic-associated fatty liver disease and lipoprotein metabolism","volume":"50","author":"Heeren","year":"2021","journal-title":"Mol Metab"},{"issue":"3","key":"10.1016\/j.eprac.2024.09.012_bib35","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.ecl.2023.01.003","article-title":"Lipid disorders and metabolic-associated fatty liver disease","volume":"52","author":"Anwar","year":"2023","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"10","key":"10.1016\/j.eprac.2024.09.012_bib36","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.molmed.2011.05.013","article-title":"Biological activities of HDL subpopulations and their relevance to cardiovascular disease","volume":"17","author":"Camont","year":"2011","journal-title":"Trends Mol Med"},{"issue":"4","key":"10.1016\/j.eprac.2024.09.012_bib37","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1002\/hep.30908","article-title":"Lean NAFLD: a distinct entity shaped by differential metabolic adaptation","volume":"71","author":"Chen","year":"2020","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.eprac.2024.09.012_bib38","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/ajg.2016.318","article-title":"Clinical and metabolic characterization of lean Caucasian subjects with non-alcoholic fatty liver","volume":"112","author":"Feldman","year":"2017","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.eprac.2024.09.012_bib39","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.2147\/DMSO.S462003","article-title":"Cardiometabolic and metabolic profiles of lean\/normal, overweight and obese patients with nonalcoholic fatty liver disease","volume":"17","author":"Wang","year":"2024","journal-title":"Diabetes Metab Syndr Obes"},{"issue":"suppl","key":"10.1016\/j.eprac.2024.09.012_bib40","doi-asserted-by":"crossref","first-page":"S58","DOI":"10.3350\/cmh.2022.0350","article-title":"Comparison between obese and non-obese nonalcoholic fatty liver disease","volume":"29","author":"Chan","year":"2023","journal-title":"Clin Mol Hepatol"}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X24006785?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X24006785?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T03:57:36Z","timestamp":1778817456000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X24006785"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":40,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["S1530891X24006785"],"URL":"https:\/\/doi.org\/10.1016\/j.eprac.2024.09.012","relation":{},"ISSN":["1530-891X"],"issn-type":[{"value":"1530-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of Risk Factors Between Lean and Nonlean Metabolic Dysfunction-Associated Steatotic Liver Disease in Individuals With Type 2 Diabetes: A Multicenter Study","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eprac.2024.09.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 AACE. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}